Lidia arrives at her family doctor’s office with a new flare-up of dyshidrotic eczema, convinced, as she has been on previous occasions, that the trigger is the intense stress she has experienced for months. This time, however, her doctor explains the brain-skin axis, drawing on recent research showing that the relationship between psychological stress and skin inflammation is more complex than previously thought. Stress may trigger a flare-up, but it is not considered the underlying cause. Rather, it may amplify inflammation through specific biological mechanisms.

This shift in perspective does not diminish the importance of emotional factors. Instead, it suggests that stress can influence disease through neuroimmune pathways that modify the inflammatory response in the skin. The distinction may be subtle, but it has implications for clinical practice and the development of new treatment strategies.

Dyshidrotic eczema, also known as pompholyx, is an inflammatory skin condition that can significantly affect quality of life. The intensely itchy blisters that develop on the palms of the hands and soles of the feet can interfere with everyday activities such as writing, working, and sleeping.

Emotional stress is one factor that may contribute to flare-ups, but it is now viewed more as a modulator of a multifactorial disease involving genetic predisposition, impaired skin barrier function, immune and inflammatory responses, and other environmental factors.

From Stress to Inflammation

The biological basis for this relationship was described in a study published in Science in 2026. Researchers identified a specific mechanism linking psychological stress to skin inflammation. They showed that activation of the sympathetic nervous system triggers a neuronal signal that promotes the recruitment and activation of eosinophils, which are involved in the inflammatory response.

In animal models, this pathway was associated with worsening dermatitis, with the findings supported by clinical data from patients with eczema. Although the study did not specifically examine dyshidrotic eczema, it provides proof of concept that stress can modulate inflammation through neuroimmune pathways.

The findings are consistent with previous findings showing that psychological stress can disrupt skin homeostasis by affecting sleep quality, increasing anxiety, and impairing the epidermal barrier. In dyshidrotic eczema, which primarily affects the hands and feet, this may be particularly relevant because impaired barrier function can increase the skin’s vulnerability to external irritants.

Available evidence also suggests that stress rarely acts alone. Individuals with dyshidrotic eczema may have a history of atopic dermatitis, sensitization to metals such as nickel or cobalt, or other predisposing factors. Together, these findings support the view that stress may amplify existing inflammatory processes rather than serve as the initial cause of the disease.

The Brain-Skin Connection

This model is based on the brain-skin axis, a continuous communication system between two organs that share an embryologic origin. Through neural, hormonal, and immune signals, the brain and skin constantly exchange information. When an individual experiences stress, the hypothalamic-pituitary-adrenal axis and sympathetic nervous system are activated, triggering the release of hormones and neuropeptides that can alter the activity of various skin cells.

A 2026 review published in Biomolecules describes the role of neuroinflammation in this process. Nerve fibers in the skin do more than transmit sensations such as itch and pain; they also actively regulate immune responses by releasing molecules such as substance P. This neuropeptide can directly activate mast cells, which play a key role in inflammation, promoting the release of histamine and other inflammatory mediators that contribute to itching and inflammation.

The nervous and immune systems continuously interact, with each influencing the other and helping sustain the inflammatory response. This new perspective moves away from the traditional view, which attributed inflammation primarily to allergic mechanisms or the adaptive immune response, and recognizes a greater role for the nervous system.

The Itch-Scratch Cycle

A related concept that helps explain the experience of many individuals is the itch-scratch cycle, described in a 2025 review in Dermatology and Therapy. Stress can increase sensitivity to itch, prompting intense scratching. Scratching then disrupts the skin barrier and promotes the release of additional inflammatory mediators, which further increase inflammation and itching, creating a cycle that can perpetuate a flare-up.

This cycle may help explain why some individuals report that periods of stress not only precede flare-ups but also make them more intense or prolonged. Rather than indicating a direct cause-and-effect relationship between stress and eczema, the findings point to a biological amplification process.

This evolving understanding of the disease is also informing research into new treatment options. Research on cytokines such as interleukin (IL)-4, IL-13, and IL-31, and pathways linking nerves and immune cells is driving the development of treatments targeting specific mechanisms of skin inflammation. Although much of this work has focused on atopic dermatitis and chronic hand eczema, which are related to dyshidrotic eczema, some of these findings may also be relevant to dyshidrotic eczema.

A 2025 study published in Archives of Dermatological Research examined receptors on mast cells, such as Mas-related G protein-coupled receptor X2, opening additional avenues for research into blocking neurogenic inflammation.

Can Stress Be Targeted?

Given the emerging evidence of continuous interaction among the nervous system, immune system, and skin barrier in triggering flare-ups, could targeting stress have a therapeutic role?

To date, no robust clinical trials have shown that stress reduction alone can prevent dyshidrotic eczema flare-ups. However, evidence from other inflammatory skin diseases suggests that interventions such as cognitive-behavioral therapy, stress reduction techniques, and improved sleep may reduce the impact of itch, improve treatment adherence, and enhance quality of life.

This approach is consistent with the emerging pathophysiologic model. If stress acts as an amplifier of inflammation, addressing it may help interrupt the cycle linking itch, scratching, and damage to the skin barrier while complementing dermatologic treatment.

In the Science study, the authors concluded that managing psychological stress could represent an important therapeutic approach in dermatitis. The findings do not change the clinical management of dyshidrotic eczema, but they strengthen research into neuroinflammation as a link between the nervous system and skin inflammation.

Lidia may still believe that accumulated stress contributed to her latest flare-up. The difference is that she now understands that the connection is not simply a matter of perception but may reflect a complex interaction among the brain, immune system, and skin. This new perspective could eventually lead to treatments designed to break this cycle before inflammation becomes chronic.

This article was translated from El Médico Interactivo on Univadis, part of the Medscape Professional Network.